China Shineway Pharmaceutical Group Limited
Shineway’s OTC products made their way into 780 pharmacy chains
Shineway’s OTC products made their way into 780 pharmacy chains
Other Shineway news: 1. In May 2018, several provinces abandoned the low-price drug approval requirement so that such medications are no longer required to first enter into low price drugs catalogue. Hence, TCM with consumption not more than RMB 5 daily, are to be procured according to the relevant low-price drug policy and not subject to tendering. Qing Kai Ling Injection, as a beneficiary of such policy change, is accelerating its price hike in the relevant provinces. 2. Shineway’s TCM Formula Granules were officially launched at the Cangzhou Hospital of Integrated TCM and Western Medicine of Hebei Province in May 2018. A total of 6 highly efficient smart medicine dispensing system new models were installed and each system can handle 100 prescriptions per day. The hospital is among the first batch of Class III-A integrated hospitals in China. It is also one of the ten key integrated TCM & western medicine hospitals of the nation, and by far the largest in scale of collaboration by Shineway. 3. In May 2018, Anhui’s Ministry of Human Resources and Social Security released the 2018 Provincial Drug Reimbursement List, with Shineway’s Shujin Tongluo Granule and Jiangzhi Tongluo Soft Capsule admitted into the list as Category B reimbursable products. The admission is expected to further raise the profile of these two products in Anhui Province, as well as driving their consumption and sales.
Document: http://n.eqs.com/c/fncls.ssp?u=BNTRFCHUXU Document title: Shineway’s OTC products made their way into 780 pharmacy chains
26/06/2018 Dissemination of a Financial Press Release, transmitted by EQS Group. |